Characteristics and Outcome of Patients With COVID-19 Associated Respiratory Failure Treated in South Tyrol, Italy
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- COVID-19
- Sponsor
- Institute of Mountain Emergency Medicine
- Enrollment
- 550
- Locations
- 1
- Primary Endpoint
- Mortality
- Status
- Completed
- Last Updated
- 4 years ago
Overview
Brief Summary
The investigators retrospectively investigate the epidemiology, clinical characteristics and therapeutic interventions of patients with COVID-19 associated respiratory failure admitted to the intensive care units in South Tyrol, Italy.
Detailed Description
In this observational, retrospective study the epidemiology, characteristics, therapeutic interventions and outcome of patients with COVID-19 associated respiratory failure admitted to the intensive care units in South Tyrol, Italy, are assessed. Data extracted from the medical patients' records include type and duration of respiratory support (high-flow nasal oxygen, non-invasive ventilation, invasive ventilation), need for tracheostomy, vasopressor needs, antibiotic therapy, corticosteroid treatment, laboratory values (interleukin-6, C-reactive protein, procalcitonin, D-dimer, lymphocyte count), lengths of stay in the ICU and mortality.
Investigators
Simon Rauch
Senior researcher; MD, PhD
Institute of Mountain Emergency Medicine
Eligibility Criteria
Inclusion Criteria
- •All patients admitted to the intensive care units in South Tyrol due to COVID-19 associated respiratory failure
Exclusion Criteria
- •SARS-CoV-2 patients admitted to the intensive care units in South Tyrol for other pathologies (i.e., not respiratory failure)
Outcomes
Primary Outcomes
Mortality
Time Frame: Through study completion, an average of 1 year
Mortality (dead/alive) at discharge from the ICU is defined as primary outcome